Holger Engel is a life sciences professional with over 25 years of experience in the molecular diagnostics market. They founded Ambiatec Biosolutions (2021–2025), a development service provider for high-end ultra-fast and multiplexed PCR and isothermal amplification diagnostic assay workflows for infectious diseases and other novel biomarkers. They are the CEO of ALLERGIOS (2025–Present), which is developing an AI-powered microfluidic platform for functional allergy diagnostics, and own Dr. Holger Engel - CONSULTING (2017–Present), offering technology and business consultancy in life science and molecular diagnostics. They previously held senior R&D roles at QIAGEN (Scientist R&D 2001–2006; Senior Scientist R&D 2006–2009) and served as Director of Reagents at STAT-Dx (2014–2017). They earned a Ph.D. in Molecular Biology and Immunology and a Diploma in Biology from Technische Universität Braunschweig (1990–1999).
Location
Hamm, Germany
This person is not in the org chart
This person is not in any teams
This person is not in any offices